Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LigoCyte Pharmaceuticals Inc.

Division of Takeda Pharmaceutical Co. Ltd.

Latest From Roche Pharma AG

London Tech Week: Asthma Sensors, Smartphone Health Monitoring & Eczema Management Garments

Early-stage UK businesses took center stage at a medtech-focused investor event held as part of London's Tech Week. The weeklong festival of events, June 12-16, are intended to strengthen London's status as a global tech hub and celebrate cutting-edge innovation.

StartUps and SMEs Innovation

China VC Roundup: Investors Flock To Rising Innovation, Expertise

The past few months have seen frenzied venture capital and other investment in the Chinese pharma and biotech space, driven by increasingly innovative startups run by big pharma veterans, while corporate ventures have been joining with private equity to build up specialist investment and M&A funds.

China Financing

Merck KGAA Invests €260m In Production Value Chain in China

German group Merck has inaugurated a major new pharmaceutical plant and announced a further investment in China, where it sees opportunities in essential drugs amid rising demand as the country broadens its basic healthcare coverage and its population ages.

China Manufacturing

MINDACT Trial: Agendia's MammoPrint Test Identifies No-Chemo Candidates

By identifying the patients at low risk for recurrence, MammaPrint could spare more than 100,000 women with early-stage breast cancer worldwide from unnecessary chemotherapy, according to Agendia.

In Vitro Diagnostics Cancer
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Donald P Beeman , CEO
    Larry W Mikkola, Dir., Fin.
    Robert R Goodwin, PhD, Pres. & COO
    Charles E Richardson, PhD, EVP, R&D
    Robert F Bargatze, PhD, EVP, CSO
  • Contact Info
  • LigoCyte Pharmaceuticals Inc.
    Phone: (406) 585-2733
    2155 Analysis Dr.
    Bozeman, MT 59718